Hyderabad-based Laurus Labs’ net profit remained flat ?48.8 crore in Q2 FY18, compared to ?48.3 crore in Q2 FY17. The total revenue of company grew 4.3 per cent at Rs 538 crore (Rs 516 crore).
Pfizer’s offer for the San Francisco, California-based Medivation goes far beyond the company’s market value of $11.1 billion. Medivation shares closed at $67.16 in Friday trading (Reuters)